Fulk Jennifer
SEC insider (Form 3/4/5 filer). CIK 0001873522. Chief Financial Officer at Kura Oncology, Inc. (KURA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in SAN DIEGO, CA.
Companies Fulk Jennifer has filed insider reports for
- Kura Oncology, Inc. (KURA): Officer, Chief Financial Officer
- SOLENO THERAPEUTICS INC (SLNO): Officer, CHIEF FINANCIAL OFFICER
Fulk Jennifer
CIK: 0001873522
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 8, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
450K shares- - May 18, 2026SLNO
SOLENO THERAPEUTICS INC
DispositionDirect39.2K shares- - Mar 2, 2026SLNO
SOLENO THERAPEUTICS INC
AwardDirect39.2K shares- - Mar 2, 2026SLNO
SOLENO THERAPEUTICS INC
ExerciseDirectEmployee stock option (right to buy)
67.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  KURA Kura Oncology, Inc. | Award Option to purchase common stock | 450,000 | - | - | Direct |
| May 18, 2026 |  SLNO SOLENO THERAPEUTICS INC | Disposition | 39,200 | - | $0 | Direct |
| Mar 2, 2026 | SLNO SOLENO THERAPEUTICS INC | Award | 39,200 | - | $0 | Direct |
| Mar 2, 2026 | SLNO SOLENO THERAPEUTICS INC | Exercise Employee stock option (right to buy) | 67,660 | - | - | Direct |
1-4 of 4 transactions